Skip to content
Democratizing Drug Discovery episode artwork

Sep 30, 2021 30 min

Democratizing Drug Discovery

from The Bio Report Hosted by Levine Media Group

The ability to discover new drugs can be limited by the tools and technologies small companies can access. Alloy Therapeutics says it democratizing access to a set of technologies and capabilities that are foundational for discovering and developing biologics. We spoke to Errik Anderson, CEO of Alloy Therapeutics, discusses the challenges of drug discovery the company is seeking to address, its business model, and the dealmaking it has done to build beyond platform technologies to become involved in the discovery and development of therapeutic candidates.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Democratizing Drug Discovery

0:00 30:27

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 30 minutes long.

When was this The Bio Report episode published?

This episode was published on September 30, 2021.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.